110
Participants
Start Date
December 15, 2015
Primary Completion Date
July 31, 2019
Study Completion Date
July 31, 2019
ADXS11-001
Placebo
Site, Tainan City
Site, Seoul
Site, Seoul
Site, Elche
Site, Taoyuan District
Site, Seoul
Site, Seoul
Site, Seoul
Site, Seoul
Site, Palma de Mallorca
Site, Palma de Mallorca
Site, Barcelona
Site, Barcelona
Site, Sabadell
Site, Barcelona
Site, Taipei
Site, Taipei
Site, Belgrade
Site, Belgrade
Site, Taipei
Albany
Site, Pulau Pinang
Site, Seongnam
Site, Córdoba
Site, Kota Bharu
Site, Kota Bharu
Site, Girona
Site, Vinnytsia
Site, Kamenitz
Site, Madrid
Site, Madrid
Site, Khmelnytskyi
Site, Málaga
Site, Chihuahua City
Site, Kragujevac
Site, Poltava
Site, Taichung
Site, Seville
Site, Lutsk
Site, Cincinnati
Site, Ternopil
Site, Valencia
Site, El Palmar
Site, Valencia
Site, Dnipro
Site, Zaragoza
Site, Yangsan
Site, Chernivtsi
Site, Kuala Lumpur
Site, Kharkiv
Site, Ampang
Site, Ivano-Frankivsk
Site, Orange
Site, Moscow
Site, Arkhangelsk
Site, Saint Petersburg
Site, Saint Petersburg
Site, Obninsk
Site, Krasnodar
Site, Sochi
Site, Pyatigorsk
Site, Nal'chik
Site, Volgograd
Site, Ufa
Site, Orenburg
Site, Nizhny Novgorod
SITE, Temuco
SITE, Santiago
Mobile
Site, Phoenix
Phoenix
Duarte
Long Beach
Orange
Site, San Francisco
Site, Miami
Site, Tallahassee
Tampa
Augusta
Maywood
Site, Park Ridge
Site, Indianapolis
Indianapolis
Iowa City
Scarborough
Site, Baltimore
Detroit
Minneapolis
Site, Omaha
Site, Las Vegas
Site, Hackensack
Site, Brooklyn
Charlotte
Winston-Salem
Site, Hilliard
Kettering
Oklahoma City
Philadelphia
Greenville
Chattanooga
Nashville
Site, Dallas
Site, Galveston
Houston
Milwaukee
Site, Rostov-on-Don
Site, Zaporizhzhya
Site, Newark
Site, La Rioja
Site, Rio de Janeiro
Site, Natal
SITE, Calgary
SITE, Montreal
Site, Sherbrooke
Site, Mexico City
Site, Bialystok
Site, Lublin
Lead Sponsor
Gynecologic Oncology Group
NETWORK
Advaxis, Inc.
INDUSTRY